No Image
Monoclonal Antibodies
Anti-CREB3L2 Monoclonal Antibody for WB, IHC-P, IF/ICC, ELISA - Q70SY1
Item Number : CM0005660
Price varies based on specs and customizations
- Application
- WB, IHC-P, IF/ICC, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 57 kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | CREB3L2 Rabbit mAb |
| Remarks/Alias | BBF2H7 |
| Species | Human |
| GeneID (Human) | 64764 |
| GeneID | 64764 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-247 of human CREB3L2 (NP_001240704.1) |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, IHC-P, IF/ICC, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | Q70SY1 |
| Protein Weight | 57 kDa |
| Shipping | Ice bag |
Biological Background: CREB3L2 Function and Localization
- CREB3L2, also known as BBF2H7, is a transcription factor belonging to the CREB/ATF family that mediates the unfolded protein response (UPR).
- Under basal conditions, CREB3L2 is anchored in the endoplasmic reticulum (ER) membrane, with its N‑terminal transcription activation and DNA‑binding domains facing the cytosol.
- Endoplasmic reticulum stress triggers transport to the Golgi, where regulated intramembrane proteolysis by S1P/MBTPS1 and S2P/MBTPS2 releases the N‑terminal fragment for nuclear import and gene activation.
- In vitro, the released N‑terminal fragment binds directly to CRE sites and activates transcription of target genes.
- Related references: PMID:17178827
- In a neuroblastoma cell model, CREB3L2 protects cells from ER stress‑induced apoptosis.
- Related references: PMID:17178827
- CREB3L2 plays a critical role in chondrogenesis by activating SEC23A transcription, which promotes the secretion of cartilage matrix proteins (By similarity).
- Subcellularly, the full‑length protein resides in the ER membrane, while the cleaved active form translocates to the nucleus to regulate gene expression.
- CREB3L2 is widely expressed, with highest levels in placenta, lung, spleen, and intestine, and lowest in heart, brain, and skeletal muscle.
Experimental Guidance and Technical Tips
- The immunogen corresponds to the N‑terminal region (aa 1‑247) of human CREB3L2, encompassing the transcription activation and DNA‑binding domains; this region is retained in the cleaved active form, so the antibody may detect both full‑length (57 kDa) and cleaved N‑terminal fragments in WB under reducing conditions.
- For WB, consider using cultured cell lines exposed to ER stress inducers (e.g., tunicamycin) to monitor CREB3L2 cleavage and activation.
- In IHC‑P, expect nuclear staining after ER stress activation; validate in tissues with known high expression such as placenta or lung.
- For IF/ICC, permeabilization is required to access the cytosolic/nuclear epitope; optimize fixation and permeabilization conditions.
- As a rabbit monoclonal antibody, it offers high specificity and batch‑to‑batch consistency; however, we recommend titrating the antibody for each assay to determine the optimal working dilution.
CamelBio: Your One‑Stop Sourcing Bridge
CamelBio provides a complete range of IVD raw materials and technical services, supporting your project from concept to clinic. For ER stress and chondrogenesis research, our portfolio includes validated antibody pairs, recombinant proteins, and ancillary reagents tailored to your assay development needs. Partner with us to streamline sourcing of rare‑target and bulk raw materials.
Product Datasheet
Anti-CREB3L2 Monoclonal Antibody for WB, IHC-P, IF/ICC, ELISA - Q70SY1
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!